drugset / Trial / NCT06649877

MK-6194 Site of Injection Study in Healthy Adult Participants (MK-6194-013)

NCT06649877 ↗

Phase 1 Completed 16 enrolled Merck Sharp & Dohme LLC
RandomizedCrossoverOpen-labelBasic science

Summary

The goal of this study is to learn what happens to MK-6194 in a healthy person's body when different injection sites are used. Researchers will compare what happens to MK-6194 in a healthy person's body when it is injected into the abdomen and when it is injected into the thigh. Researchers think that the average amount of MK-6194 in a person's body over time will be similar when injected into the thigh or abdomen. They also want to learn if it is safe to inject MK-6194 into the abdomen and thigh, and if people tolerate it.

Timeline

Start
2023-03-20
Primary completion
2023-07-13
Completion
2023-07-13

Drugs

EvaluationDrugModalityDoseRoute
Subject MK-6194 Unknown — Subcutaneous

Indications

No indication recorded.